THE 60 GY IN 3 TO 5 FRACTIONS RECOMMENDATION FOR STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR STAGE I NON-SMALL CELL LUNG CANCER (NSCLC) IS OVERKILL: A PLEA FOR A INDIVIDUALISED DOSE PRESCRIPTION

被引：0
|
作者：
De Ruysscher, D. [1 ]
van Baardwijk, A. [2 ]
Tome, W. [3 ]
Bentzen, S. [3 ]
Wanders, S. [2 ]
Reymen, B. [2 ]
Borger, J. [2 ]
van Elmpt, W. [2 ]
Ollers, M. [2 ]
Lambin, P. [2 ]
机构：
[1] MUCM, Maastricht, Netherlands
[2] MAASTRO Clin, Maastricht, Netherlands
[3] Univ Wisconsin, Sch Med & Publ H, Madison, WI USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1044
引用
收藏
页码：S356 / S357
页数：2
相关论文
共 50 条
  • [1] Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review
    van Baardwijk, Angela
    Tome, Wolfgang A.
    van Elmpt, Wouter
    Bentzen, Soren M.
    Reymen, Bart
    Wanders, Rinus
    Houben, Ruud
    Oilers, Michel
    Lambin, Philippe
    De Ruysscher, Dirk
    RADIOTHERAPY AND ONCOLOGY, 2012, 105 (02) : 145 - 149
  • [2] Hypofractionated stereotactic body radiotherapy (SBRT) for medically unresectable stage I non-small cell lung cancer (NSCLC)
    Nambiar, A. P.
    Ajlouni, M.
    Jin, J.
    Ryu, S.
    Kim, J. H.
    Movsas, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S484 - S484
  • [3] Stereotactic body radiotherapy (SBRT, BED ≥ 100 Gy) for operable stage I non-small cell lung cancer:: Is SBRT comparable to surgery?
    Onishi, H.
    Nagata, Y.
    Shirato, H.
    Arimoto, T.
    Gomi, K.
    Karasawa, K.
    Hayakawa, K.
    Takai, Y.
    Ouchi, A.
    Takeda, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S86 - S87
  • [4] Stereotactic body radiotherapy (SBRT) for elderly patients with early stage non-small cell lung cancer (NSCLC)
    Mitsuyoshi, T.
    Kawaguchi, Y.
    Konishi, K.
    Teshima, T.
    Nishiyama, K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S809 - S809
  • [5] Time Will Tell: Is 60 Gy in 3 Fractions the Optimal SBRT Schedule for Stage I Non-Small Cell Lung Cancer?
    Stephans, K.
    Woody, N. M.
    Reddy, C. A.
    Magnelli, A.
    Zhaung, T.
    Djemil, T.
    Videtic, G. M. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S28 - S28
  • [6] Stereotactic Body Radiotherapy (SBRT) or Surgery in Early Stage (I & II) Non Small Cell Lung Cancer (NSCLC)
    Koyi, Hirsh
    Hillerdal, Gunnar
    Friesland, Signe
    Kolbeck, Karl Gustav
    Andersson, Olov
    Bergman, Per
    Orre, Lotta
    Liv, Per
    Branden, Eva
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S566 - S566
  • [7] Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients
    Ceniceros, L.
    Aristu, J.
    Castanon, E.
    Rolfo, C.
    Legaspi, J.
    Olarte, A.
    Valtuena, G.
    Moreno, M.
    Gil-Bazo, I.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (03): : 259 - 268
  • [8] Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients
    L. Ceniceros
    J. Aristu
    E. Castañón
    C. Rolfo
    J. Legaspi
    A. Olarte
    G. Valtueña
    M. Moreno
    I. Gil-Bazo
    Clinical and Translational Oncology, 2016, 18 : 259 - 268
  • [9] FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer
    Hoopes, D
    Tann, M
    McGarry, R
    Lo, S
    Timmerman, R
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S225 - S225
  • [10] Stereotactic body radiotherapy for stage I non-small cell lung cancer
    Martel-Lafay, I.
    ONCOLOGIE, 2012, 14 (05) : 282 - 288
12345